Recent Patents on Anti-Cancer Drug Discovery,volume 12,issue 3  (09-2017)

Period of time： 2017年3期

Publisher： Bentham Science Publishers

Founded in： 2006

Total resources： 37

E-ISSN： 2212-3970|12|3

ISSN： 1574-8928

Subject： R73 Oncology

Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Recent Patents on Anti-Cancer Drug Discovery,volume 12,issue 3

Menu

Meet Our Editorial Board Member

Recent Patents on Anti-Cancer Drug Discovery,volume 12,issue 3 , Vol. 12, Iss. 3, 2017-09 , pp. 189-189

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Pharmacological Inhibitors of NAD Biosynthesis as Potential An ticancer Agents

Recent Patents on Anti-Cancer Drug Discovery,volume 12,issue 3 , Vol. 12, Iss. 3, 2017-09 , pp. 190-207

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Poly (ADP-Ribosyl) Polymerase 1 Inhibitors: A Patent Review

Recent Patents on Anti-Cancer Drug Discovery,volume 12,issue 3 , Vol. 12, Iss. 3, 2017-09 , pp. 208-220

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Immune Cells Act as Promising Targets for the Treatment of Bone Metastasis

Recent Patents on Anti-Cancer Drug Discovery,volume 12,issue 3 , Vol. 12, Iss. 3, 2017-09 , pp. 221-233

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Epithelial Mesenchymal Transition in Cancer Progression: Prev entive Phytochemicals

Recent Patents on Anti-Cancer Drug Discovery,volume 12,issue 3 , Vol. 12, Iss. 3, 2017-09 , pp. 234-246

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Role of FoxM1 in the Progression and Epithelial to Mesenchymal Transition of Gastrointestinal Cancer

Recent Patents on Anti-Cancer Drug Discovery,volume 12,issue 3 , Vol. 12, Iss. 3, 2017-09 , pp. 247-259

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

In Vitro Collapsing Colon Cancer Cells by Selectivity of Disulfiram-Loaded Charge Switchable Nanoparticles Against Cancer Stem Cells

Recent Patents on Anti-Cancer Drug Discovery,volume 12,issue 3 , Vol. 12, Iss. 3, 2017-09 , pp. 260-271

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Indication of Bevacizumab for Cerebral Radiation Necrosis

Recent Patents on Anti-Cancer Drug Discovery,volume 12,issue 3 , Vol. 12, Iss. 3, 2017-09 , pp. 272-277

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Patent Selections

Recent Patents on Anti-Cancer Drug Discovery,volume 12,issue 3 , Vol. 12, Iss. 3, 2017-09 , pp. 278-279

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Total 9 item(s)